Marsh & McLennan Companies, Inc.

Fundamentals7.0
Price Action4.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Margin Stability
  • Strong Cash Flow
  • Balance Sheet Mix

AI
AI Summary

6.0

Marsh McLennan remains a high-quality, capital-efficient franchise, but with underlying growth slowing to 4% and the stock already de-rating, the investment case now hinges on proof of reacceleration or margin expansion—otherwise the premium valuation looks hard to defend, especially if shares fail to reclaim the 167–170 resistance zone or lose 159 support.

ExecutionRisk
ValuationRisk
TechnicalLevel‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • Margin Stability
  • Strong Cash Flow
  • Balance Sheet Mix

MRSH shows strong, steady profitability and cash generation with high returns on capital, but leverage, heavy intangibles, and a mid-teens earnings multiple mean the investment case depends on continued execution rather than cheap valuation.

profitable
steady

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Lower highs
  • Support test
  • Weak bounce

MRSH remains in a last month downtrend, with only tentative stabilization near $159-$160 and resistance at $163-$167, so the bounce is still unconfirmed.

downtrend
support
Support Level: $159.14-$160
Resistance Level: $163-$167

Rebounded modestly after hitting $159.14, but the move is small versus the prior decline

Sentiment & News

6.0

Key News Insights:

  • Pricing Pressure
  • AI Expansion
  • Deal Growth

Marsh McLennan posted a solid Q1 with steady growth and margin discipline, but pricing and fiduciary income pressures persist even as AI-enabled services, partnerships, and acquisitions support longer-term expansion at roughly fair value.

AI
Expansion

The headlines point to a resilient but fairly valued MRSH, with upside tied to execution on AI, acquisitions, and operating efficiency